Light Chain Bioscience | Novimmune SA
NovImmune has successfully divested EmaCo AG, a newly established company owning emapalumab and related assets to Sobi on 18 July 2019. NovImmune SA will continue to operate and focus on its bispecif...load more
Light Chain Bioscience | Novimmune SA's Basic Information
Industry
Headquarters
Switzerland
Website
Founded Year
1998
Headcount
51 - 200 ( View All )
Specialties
Next-generation antibody drug discoveryImmunologyBispecific antibody drugsClinical development
Light Chain Bioscience | Novimmune SA's Competitors
Employee Insights
Light Chain Bioscience | Novimmune SA's Top Employees
Franck Gueneau
Research Associate
Phone Email
Laurence Chatel
Research Associate
Phone Email
Herren Suzanne
Senior Research Associate
Phone Email
Soheila Emamzadah
Research Associate
Phone Email
Sébastien Calloud
Research Associate IN Phage Display Platform
Phone Email
Frequently Asked Questions Regarding Light Chain Bioscience | Novimmune SA
Connect with anyone with AroundDeal today!
Whether you're looking to connect with key decision-makers or making remote or global hires, we've got you covered.
✔ GDPR aligned & CCPA compliant✔ Cancel anytime✔ 5 free contacts